Correlation Between Inozyme Pharma and Arcellx
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Arcellx, you can compare the effects of market volatilities on Inozyme Pharma and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Arcellx.
Diversification Opportunities for Inozyme Pharma and Arcellx
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inozyme and Arcellx is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Arcellx go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Arcellx
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Arcellx. In addition to that, Inozyme Pharma is 1.02 times more volatile than Arcellx. It trades about -0.73 of its total potential returns per unit of risk. Arcellx is currently generating about 0.08 per unit of volatility. If you would invest 8,499 in Arcellx on August 28, 2024 and sell it today you would earn a total of 442.00 from holding Arcellx or generate 5.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Arcellx
Performance |
| Timeline |
| Inozyme Pharma |
| Arcellx |
Inozyme Pharma and Arcellx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Arcellx
The main advantage of trading using opposite Inozyme Pharma and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |